Dr Don Charles Harting, MD in Cleveland, TN - Dermatology

Dr Don Charles Harting, MD is a Dermatology physician based in Cleveland, Tennessee. Dr Don Charles Harting is licensed to practice in Tennessee (license number MD9328) and his current practice location is 2200 Chambliss Ave Nw, Cleveland, Tennessee. He can be reached at his office (for appointments etc.) via phone at (423) 479-8648.

NPI number for Dr Don Charles Harting is 1568528693 and his current mailing address is 2200 Chambliss Ave Nw, Cleveland, Tennessee. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1568528693.

Contact Information

	Dr Don Charles Harting, MD
	2200 Chambliss Ave Nw, Cleveland, TN 37311-3874
	(423) 479-8648
	(423) 479-8649

Physician's Profile

Full Name	Dr Don Charles Harting
Gender	Male
Speciality	Dermatology
Location	2200 Chambliss Ave Nw, Cleveland, Tennessee
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1568528693
Provider Enumeration Date: 01/01/2007
Last Update Date: 12/17/2013

Medical Identifiers

Medical identifiers for Dr Don Charles Harting such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568528693	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	MD9328 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Don Charles Harting is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Don Charles Harting, MD 2200 Chambliss Ave Nw, Cleveland, TN 37311-3874 Ph: (423) 479-8648	Dr Don Charles Harting, MD 2200 Chambliss Ave Nw, Cleveland, TN 37311-3874 Ph: (423) 479-8648

News Archive

Blood emergency declared in New York supply

As a result of last week's extreme humidity and high temperatures, blood donations fell by 25% leaving the community blood supply at risk and in a critical state far below what is required to adequately serve local patients.

Ongoing treatment with nivolumab shows benefit in advanced kidney cancer patients

Only 12% of kidney cancer patients with advanced disease survive five years after their initial treatment. In a Roswell Park Cancer Institute-led study, scientists report that some patients with advanced kidney cancer who continued to receive a novel immunotherapy drug after their disease progressed saw clinical benefit.

YM BioSciences announces results of collaborative antibody development program

YM BioSciences Inc., today announced the first results of a collaborative program between YM and the National Research Council of Canada's Biotechnology Research Institute (NRC-BRI). Utilizing YM's IntelliMab(TM) technology, the program is designed to generate novel antibodies that target cell surface receptors associated with cancer, uniquely optimized to produce efficacy with reduced toxicities.

Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer treatment

Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.

U.S. researchers who collaborate with international scientists more likely to receive greater recognition

U.S. researchers who collaborate with international scientists are more likely to have their work cited than peers who do not utilize overseas expertise, according to a new study released this week by Rice University's Baker Institute for Public Policy.

Dr Don Charles Harting, MD - Dermatology in Cleveland, TN